{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T04:27:29Z","timestamp":1783744049789,"version":"3.55.0"},"reference-count":30,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2013,1,3]],"date-time":"2013-01-03T00:00:00Z","timestamp":1357171200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0053521","type":"journal-article","created":{"date-parts":[[2013,1,4]],"date-time":"2013-01-04T00:54:11Z","timestamp":1357260851000},"page":"e53521","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":38,"title":["Inhibition of Sphingosine Kinase-2 in a Murine Model of Lupus Nephritis"],"prefix":"10.1371","volume":"8","author":[{"given":"Ashley J.","family":"Snider","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip","family":"Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina M.","family":"Obeid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jim C.","family":"Oates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,1,3]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1038\/ki.1997.162","article-title":"Cyclophosphamide therapy for lupus nephritis: poor renal survival in black Americans. Glomerular Disease Collaborative Network","volume":"51","author":"MA Dooley","year":"1997","journal-title":"Kidney International"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/ki.1984.75","article-title":"Diffuse proliferative lupus nephritis: identification of specific pathologic features affecting renal outcome","volume":"25","author":"HA Austin 3rd","year":"1984","journal-title":"Kidney Int"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1191\/0961203306lu2264oa","article-title":"Association of glomerular podocytopathy and nephrotic proteinuria in mesangial lupus nephritis","volume":"15","author":"TS Han","year":"2006","journal-title":"Lupus"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"19513","DOI":"10.1074\/jbc.M002759200","article-title":"Molecular cloning and functional characterization of a novel mammalian sphingosine kinase type 2 isoform","volume":"275","author":"H Liu","year":"2000","journal-title":"J Biol Chem"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1038\/ki.2008.396","article-title":"Increased survival and reduced renal injury in MRL\/lpr mice treated with a novel sphingosine-1-phosphate receptor agonist","volume":"74","author":"SE Wenderfer","year":"2008","journal-title":"Kidney Int"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.bbrc.2010.03.078","article-title":"FTY720 exerts a survival advantage through the prevention of end-stage glomerular inflammation in lupus-prone BXSB mice","volume":"394","author":"S Ando","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/nrm2329","article-title":"Principles of bioactive lipid signaling: lessons from sphingolipids","volume":"9","author":"YA Hannun","year":"2008","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.molmed.2007.06.002","article-title":"Translational aspects of sphingolipid metabolism","volume":"13","author":"YH Zeidan","year":"2007","journal-title":"Trends Mol Med"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1046\/j.1523-1755.2001.060002653.x","article-title":"Mycophenolate mofetil combined with a cyclooxygenase-2 inhibitor ameliorates murine lupus nephritis","volume":"60","author":"C Zoja","year":"2001","journal-title":"Kidney Int"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1681\/ASN.V971202","article-title":"Upregulation of renal and systemic cyclooxygenase-2 in patients with active lupus nephritis","volume":"9","author":"S Tomasoni","year":"1998","journal-title":"Journal of the American Society of Nephrology"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1007\/s10875-012-9710-3","article-title":"Increased serum concentration of sphingosine-1-phosphate in juvenile-onset systemic lupus erythematosus","volume":"32","author":"L Watson","year":"2012","journal-title":"J Clin Immunol"},{"key":"ref12","first-page":"707","article-title":"Effects of FTY720 in MRL-lpr\/lpr mice: therapeutic potential in systemic lupus erythematosus","volume":"29","author":"H Okazaki","year":"2002","journal-title":"J Rheumatol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1177\/0961203306073136","article-title":"New immunosuppresor strategies in the treatment of murine lupus nephritis","volume":"16","author":"G Alperovich","year":"2007","journal-title":"Lupus"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1399-0012.2006.00596.x","article-title":"FTY720 (fingolimod) in renal transplantation","volume":"20","author":"K Budde","year":"2006","journal-title":"Clin Transplant"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0065-2776(08)60342-9","article-title":"Murine models of systemic lupus erythematosus","volume":"37","author":"AN Theofilopoulos","year":"1985","journal-title":"Advances in Immunology"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1124\/jpet.109.163444","article-title":"Pharmacology and antitumor activity of ABC294640, a selective inhibitor of sphingosine kinase-2","volume":"333","author":"KJ French","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1007\/s10620-007-0133-6","article-title":"Suppression of ulcerative colitis in mice by orally available inhibitors of sphingosine kinase","volume":"53","author":"LW Maines","year":"2008","journal-title":"Dig Dis Sci"},{"key":"ref18","unstructured":"Smith CD, French KJ, Xia Z (2007) Sphingosine kinase inhibitors and methods of their use. In: US Patent Office P, editor. United States."},{"key":"ref19","doi-asserted-by":"crossref","first-page":"7423","DOI":"10.4049\/jimmunol.177.10.7423","article-title":"Role of MHC-linked genes in autoantigen selection and renal disease in a murine model of systemic lupus erythematosus","volume":"177","author":"H Sekine","year":"2006","journal-title":"J Immunol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/978-1-4419-6741-1_3","article-title":"Sphingolipid analysis by high performance liquid chromatography-tandem mass spectrometry (HPLC-MS\/MS)","volume":"688","author":"J Bielawski","year":"2010","journal-title":"Adv Exp Med Biol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1006\/clin.1997.4332","article-title":"Effect of late modulation of nitric oxide production on murine lupus","volume":"83","author":"JC Oates","year":"1997","journal-title":"Clin Immunol Immunopathol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/0090-1229(89)90008-1","article-title":"Genetic control of inflammatory arthritis in congenic lpr mice","volume":"53","author":"GS Gilkeson","year":"1989","journal-title":"Clin Immunol Immunopathol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"6481","DOI":"10.4049\/jimmunol.173.10.6481","article-title":"Decreased expression of the Ets family transcription factor Fli-1 markedly prolongs survival and significantly reduces renal disease in MRL\/lpr mice","volume":"173","author":"XK Zhang","year":"2004","journal-title":"J Immunol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"3738","DOI":"10.1002\/art.22955","article-title":"Association of reactive oxygen and nitrogen intermediate and complement levels with apoptosis of peripheral blood mononuclear cells in lupus patients","volume":"56","author":"JC Oates","year":"2007","journal-title":"Arthritis Rheum"},{"key":"ref25","first-page":"786","article-title":"Modulation of renal disease in MRL\/lpr mice genetically deficient in the alternative complement pathway factor B. Journal of Immunology","volume":"164","author":"H Watanabe","year":"2000"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.4049\/jimmunol.1000644","article-title":"Genetic sphingosine kinase 1 deficiency significantly decreases synovial inflammation and joint erosions in murine TNF-alpha-induced arthritis","volume":"185","author":"DA Baker","year":"2010","journal-title":"J Immunol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1172\/JCI112284","article-title":"Increased renal thromboxane production in murine lupus nephritis","volume":"77","author":"VE Kelley","year":"1986","journal-title":"Journal of Clinical Investigation"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0090-6980(91)90090-3","article-title":"Physiologic role for enhanced renal thromboxane production in murine lupus nephritis","volume":"42","author":"RF Spurney","year":"1991","journal-title":"Prostaglandins"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.bbalip.2004.01.006","article-title":"Sphingosine-1-phosphate receptors: receptor specificity versus functional redundancy","volume":"1682","author":"TA Taha","year":"2004","journal-title":"Biochim Biophys Acta"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1038\/sj.bjp.0707171","article-title":"FTY720 suppresses interleukin-1beta-induced secretory phospholipase A2 expression in renal mesangial cells by a transcriptional mechanism","volume":"150","author":"C Xin","year":"2007","journal-title":"Br J Pharmacol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0053521","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,5]],"date-time":"2022-02-05T05:22:37Z","timestamp":1644038557000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0053521"}},"subtitle":[],"editor":[{"given":"Amr H.","family":"Sawalha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,1,3]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2013,1,3]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0053521","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,3]]}}}